Our hypothesis was that oral adjunct therapy with PBA alone or in combination with vitD3 to TB patients would increase the expression of the AMP LL-37, a marker for multiple AMPs, in alveolar macrophages and pulmonary epithelium and eventually accelerate elimination of Mtb bacilli from the respiratory tract. This evidence concerns the gene ADSL and tuberculosis.